Quotient Sciences and Acesion Pharma have formed a new collaboration to apply AI‑enhanced formulation development within Quotient’s Translational Pharmaceutics platform. The partnership will support ...

Kither Biotech has started dosing patients in its phase 1b / 2a clinical study of KIT2014 in adults with moderate to severe ...

Teva has received US FDA approval for DEGEVMA (denosumab‑adet), a biosimilar to Xgeva, marking a further step in its Pivot to Growth strategy. The product is authorised across all Xgeva indications, ...

AbbVie has received European Commission approval for Rinvoq to treat active polyarticular juvenile idiopathic arthritis in ...

Neuraxpharm and Minoryx have announced that the European Commission has granted marketing authorisation under exceptional ...

Maternity care is one of the most fundamental components of any healthcare system. It shapes not only the health of mothers ...

For years, the functional service provider (FSP) model has given sponsors a practical way to extend internal teams and access ...

Merck has announced that NICE has issued final draft guidance recommending Ogsiveo for adults in England with progressing desmoid tumours who require systemic treatment. Eligible patients will gain ...

Wherever two or more MedTech start-up founders gather, the conversation follows the same depressingly familiar pattern. In the breakout areas and coffee bars of conferences and symposia around the ...

It’s been over a year since the announcement of the Single National Formulary (SNF). No question – this is a really big one for pharma, and at my new company, Life Science Access Academy, we’re ...